# Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

> **NCT02927223** · NA · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 6 (actual)

## Conditions studied

- Catecholaminergic Polymorphic Ventricular Tachycardia

## Interventions

- **DRUG:** Atropine
- **PROCEDURE:** Exercise treadmill test

## Key facts

- **NCT ID:** NCT02927223
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02927223

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02927223, "Atropine in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02927223. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*